Enanta Pharmaceuticals Inc. logo

Enanta Pharmaceuticals Inc.

ENTA | NASDAQ
Chart Builder DCF Calculator
$12.20
+$0.09 (+0.74%)
Sep 22, 2026, 11:59 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Sep 29, 2025
FY 2024
Sep 29, 2024
FY 2023
Sep 29, 2023
FY 2022
Sep 29, 2022
FY 2021
Sep 29, 2021
FY 2020
Sep 29, 2020
Cash & Equivalents
32.3M 37.23M 85.39M 43.99M 57.21M 87.13M
Short-Term Investments
156.57M 210.95M 284.52M 205.24M 186.8M 299.52M
Long-Term Investments
3.36M 3.36M 3.97M 33.25M 109.02M 33.24M
Other Long-Term Assets
92K 94K 803K 696K 92K 92K
Receivables
6.88M 38.65M 39.62M 49.04M 60.83M 23.49M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
8.59M 608K 13.26M n/a n/a 26.7M
Total Current Assets
204.34M 299.85M 422.79M 311.71M 319.02M 436.84M
Property-Plant & Equipment
72.94M 73.35M 34.71M 29.75M 10.65M 15.62M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
76.4M 76.8M 39.48M 68.88M 121.84M 53.95M
Total Assets
280.73M 376.65M 462.28M 380.59M 440.86M 490.79M
Account Payables
1.95M 8M 4.1M 6M 9.54M 5.74M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
30.71M 34.46M n/a n/a n/a 4.26M
Other Current Liabilities
n/a n/a 35.08M 14.5M 16.34M 9.38M
Total Current Liabilities
48.56M 57.54M 62.79M 29.83M 36.17M 24.16M
Long-Term Debt
112.44M 136.13M n/a 1.42M 1.51M 1.48M
Other Long-Term Liabilities
260K 231K 161.52M 454K 558K 1.08M
Total Long-Term Liabilities
167.46M 190.3M 182.75M 29.43M 5.26M 11.05M
Total Liabilities
216.02M 247.84M 245.54M 59.26M 41.43M 35.21M
Total Debt
201.06M 226.06M 26.51M 26.69M 6.84M 9.58M
Book Value
64.72M 128.81M 216.74M 321.33M 399.43M 455.58M
Book Value Per Share
3.03 6.09 10.34 15.60 19.80 22.85
Common Stock
214K 212K 211K 208K 202K 201K
Retained Earnings
-404.93M -323.04M -207M -73.18M 48.58M 127.57M
Comprehensive Income
-339K 302K -1.17M -3.72M -382K 844K
Shareholders Equity
64.72M 128.81M 216.74M 321.33M 399.43M 455.58M
Total Investments
159.93M 214.31M 288.49M 238.49M 295.82M 332.76M

© 2026 bestshares.com. All rights reserved.